CATX compared with RACC: revenue, margins and what each company keeps, and the suppliers and customers both name

CATXPerspective Therapeutics, Inc.

Mkt capRevenueRevenue

RACCResearch Alliance Corp III

Mkt capRevenueRevenue

Compare

CATXPerspective Therapeutics, Inc.

RACCResearch Alliance Corp III

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CATX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±21.1%▲+6.00%×0.28

May 12 '26±85.0%▼−2.84%×0.03

Q1 FY26±10.4%▼−5.17%×0.50

Jan 9 '26±87.1%▲+1.07%×0.01

RACC

No earnings history for RACC.

= impliedCATX realized, solidRACC realized, hatchedOne scale, both sides: full bar = 88%× = |realized| ÷ impliedSource: market data

CATXPerspective Therapeutics, Inc.

1.13▼−3.09%· post 1.13

Mkt cap$131.3MRevenue$81,000Q2 FY26Revenue$884,000FY25

RACCResearch Alliance Corp III

10.14▲+0.42%· post 10.15

ClosedOct 30 '26

Mkt cap$49.0MRevenue—Revenue—

Compare

ClosedOct 30 '26

CATXPerspective Therapeutics, Inc.

RACCResearch Alliance Corp III

1.13▼−3.09%post 1.13

Price

10.14▲+0.42%post 10.15

$131.3M

Mkt cap

$49.0M

Q2 FY26$81,000

Revenue

—

FY25$884,000

Revenue

—

CATX1.13▼−3.09%vsRACC10.14▲+0.42%ClosedOct 30 '26